From: Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus
Variable | Group 1 ECMO (n = 17)a | Group 2 Control (n = 18) | P value |
---|---|---|---|
Age median [IQR] | 45.5 [28.5–58.5] | 50 [33–63.5] | 0.484 |
Gender (male) n (%) | 12 (70.6%) | 11 (61.1%) | 0.556 |
Weight (kg) | 87.4 (25.4) | 87.5 (21.4) | 0.989 |
Height (cm) | 167.4 (10.1) | 161.6 (6.1) | 0.100 |
Body surface area (kg/m−2) | 1.95 (0.31) | 1.90 (0.26) | 0.712 |
APACHE II median [IQR]b | 27.8 [23–29.8] | 31 [24–29.5] | 0.120 |
Pregnancy n (%) | 1 (5.9%) | 1 (5.6%) | 0.493 |
Comorbidities n (%) | |||
Diabetes | 8 (47.1%) | 10 (55.6%) | 0.616 |
Hypertension | 5 (29.1%) | 7 (38.9%) | 0.725 |
Coronary artery disease | 1 (5.9%) | 1 (5.6%) | 0.493 |
Heart failure | 0 (0%) | 1 (5.6%) | 0.975 |
Bronchial asthma | 2 (11.8%) | 2 (11.1%) | 0.638 |
COPDc | 2 (11.8%) | 0 (0%) | 0.442 |
Acute kidney injury | 2 (11.8%) | 1 (5.6%) | 0.975 |
Chronic kidney disease | 1 (5.9%) | 4 (22.2%) | 0.371 |
Liver disease | 0 (0%) | 2 (11.1%) | 0.493 |
Immunocompromised | 0 (0%) | 1 (5.6%) | 0.975 |
Preexisting risk factors for ARDS n (%)d | 0 (0%) | 0 (0%) | |
Bacterial co-infection n (%) | 7 (41.2%) | 4 (22.2%) | 0.401 |